Article ID Journal Published Year Pages File Type
4002661 American Journal of Ophthalmology 2012 12 Pages PDF
Abstract
Reduced-fluence PDT combined with bevacizumab for PCV seemed to be effective for improving vision and reducing complications. Further study to optimize the light dose of PDT in combination therapy is needed in order to achieve better treatment outcomes for PCV.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Preview
Reduced-Fluence Photodynamic Therapy Combined With Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
Authors
, , ,